Evidence map›Paper›PMID 40520894›Full record

ArticleInternational journal of medical sciences2025

ABCG1 promotes the proliferation and migration of clear cell renal cell carcinoma and reduces its apoptosis.

Yihan Dong, Qiufang Qiao, Shaomin Guo, Ruibing Chen, Tianyu Lin, Xinyu Liu, Jiaxin Li, Shiming Liu, Huamao Jiang, Yong Wang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yihan DongSchool of Medical Technology, Tianjin Medical University, Tianjin 300203, China.
Qiufang QiaoSchool of Medical Technology, Tianjin Medical University, Tianjin 300203, China.
Shaomin GuoSchool of Medical Technology, Tianjin Medical University, Tianjin 300203, China.
Ruibing ChenSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300072, China.
Tianyu LinDepartment of Urology, Tianjin Institute of Urology, The second Hospital of Tianjin Medical University, Tianjin Medical University, Tianjin 300211, China.
Xinyu LiuSchool of Medical Technology, Tianjin Medical University, Tianjin 300203, China.
Jiaxin LiSchool of Medical Technology, Tianjin Medical University, Tianjin 300203, China.
Shiming LiuSchool of Medical Technology, Tianjin Medical University, Tianjin 300203, China.
Huamao JiangDepartment of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, China.
Yong WangDepartment of Urology, Tianjin Institute of Urology, The second Hospital of Tianjin Medical University, Tianjin Medical University, Tianjin 300211, China.
Dan YueSchool of Medical Technology, Tianjin Medical University, Tianjin 300203, China.
Rui WangSchool of Medical Technology, Tianjin Medical University, Tianjin 300203, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ATP Binding Cassette Transporter, Subfamily G, Member 1Carcinoma, Renal CellKidney NeoplasmsAgedApoptosisBiomarkers, TumorCell Line, TumorCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPrognosisABCG1 protein, humanATP Binding Cassette Transporter, Subfamily G, Member 1Biomarkers, TumorABCG1BenzamilClear cell renal cell carcinoma

Identifiers

PMID40520894
PMCPMC12163618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.